Survey of long‐term follow‐up programs in the United States for survivors of childhood brain tumors
Open Access
- 17 August 2009
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (7) , 1295-1301
Abstract
Introduction: Despite recognition that childhood brain tumor survivors often suffer multiple late effects following therapy, little is known regarding the long‐term follow‐up (LTFU) programs for these patients.Methods: A 16‐question survey was mailed to member institutions of the Children's Oncology Group in the United States. Institutions were asked about the size of their brain tumor program, activities of the LTFU programs and perceived barriers to follow‐up.Results: One hundred forty‐five (74%) of 197 institutions returned surveys. Care for patients 2 years following completion of therapy was provided at a designated neuro‐oncology LTFU clinic (31.2%), a general LTFU program for childhood cancer survivors (30.4%), or a general pediatric oncology program (29.7%). Institutions with a neuro‐oncology LTFU clinic were more likely to use neuro‐psychological testing following radiation therapy (P = 0.001), have longer duration of continued surveillance imaging (P = 0.02), use growth hormone replacement for medulloblastoma survivors (P < 0.001) and continue the use of growth hormone into adulthood (P = 0.05) than those with a general pediatric oncology program. Perceived barriers to care of brain tumor survivors included limited access and lack of insurance (32.1%), lack of funding or dedicated time for providers (22.9%), patients' uncertainty about need to follow‐up (20.6%), and patients' desire to not be followed in a pediatric cancer program (12.2%).Conclusions: Considerable variation exists across institutions in the United States in the delivery of follow‐up care for survivors of childhood brain tumors. We encourage additional investigation to better define and implement optimal follow‐up care for childhood brain tumor survivors. Pediatr Blood Cancer 2009; 53:1295–1301.Keywords
Funding Information
- Children's Brain Tumor Foundation
This publication has 31 references indexed in Scilit:
- Long-Term Survivors of Childhood Cancers in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2008
- Survival and Late Mortality in Long-Term Survivors of Pediatric CNS TumorsJournal of Clinical Oncology, 2007
- New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: a Report From the Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2006
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Insurance Barriers for Childhood Survivors of Pediatric Brain Tumors: The Case for Neurocognitive EvaluationsPediatric Neurosurgery, 2006
- Barriers to follow‐up care of survivors in the United States and the United KingdomPediatric Blood & Cancer, 2005
- Health care for childhood cancer survivorsCancer, 2004
- Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor RecurrenceThe Journal of Clinical Endocrinology & Metabolism, 2000
- The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhoodClinical Endocrinology, 1996